Personal tools

Coexpression cluster:C161

From FANTOM5_SSTAR

Revision as of 17:35, 18 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C161_mesothelioma_Mesothelial_acute_mesenchymal_extraskeletal_renal_placenta



Phase1 CAGE Peaks

Hg19::chr11:117150581..117150628,+p@chr11:117150581..117150628
+
Hg19::chr11:117150669..117150717,+p@chr11:117150669..117150717
+
Hg19::chr11:117152141..117152162,+p10@RNF214
Hg19::chr11:117152220..117152232,+p11@RNF214
Hg19::chr11:117152916..117152936,+p9@RNF214
Hg19::chr11:22707203..22707221,+p@chr11:22707203..22707221
+
Hg19::chr11:65629516..65629528,-p29@CFL1
Hg19::chr11:65629672..65629698,+p@chr11:65629672..65629698
+
Hg19::chr11:7506790..7506795,+p9@OLFML1
Hg19::chr11:79794715..79794718,-p@chr11:79794715..79794718
-
Hg19::chr11:90224851..90224891,+p1@AB593165
Hg19::chr12:120502465..120502470,+p12@CCDC64
Hg19::chr12:80838009..80838023,+p3@PTPRQ
Hg19::chr12:80838029..80838066,+p1@PTPRQ
Hg19::chr12:80838067..80838088,+p2@PTPRQ
Hg19::chr12:80838145..80838152,+p9@PTPRQ
Hg19::chr12:80952271..80952274,+p@chr12:80952271..80952274
+
Hg19::chr14:105952794..105952805,+p18@CRIP1
Hg19::chr14:78718132..78718157,+p@chr14:78718132..78718157
+
Hg19::chr15:83954702..83954728,-p@chr15:83954702..83954728
-
Hg19::chr16:33408291..33408306,+p@chr16:33408291..33408306
+
Hg19::chr16:33408523..33408542,+p@chr16:33408523..33408542
+
Hg19::chr17:29486054..29486065,+p12@NF1
Hg19::chr17:31107844..31107872,-p5@MYO1D
Hg19::chr17:4623333..4623376,+p@chr17:4623333..4623376
+
Hg19::chr17:4846101..4846106,+p@chr17:4846101..4846106
+
Hg19::chr17:4847813..4847819,+p@chr17:4847813..4847819
+
Hg19::chr17:55522578..55522616,+p@chr17:55522578..55522616
+
Hg19::chr17:8639180..8639188,-p@chr17:8639180..8639188
-
Hg19::chr18:39541931..39541944,+p@chr18:39541931..39541944
+
Hg19::chr18:47407103..47407112,-p@chr18:47407103..47407112
-
Hg19::chr18:60661179..60661191,+p@chr18:60661179..60661191
+
Hg19::chr19:16199781..16199806,+p@chr19:16199781..16199806
+
Hg19::chr19:38902076..38902104,-p@chr19:38902076..38902104
-
Hg19::chr1:168165301..168165329,+p@chr1:168165301..168165329
+
Hg19::chr1:168165589..168165617,+p@chr1:168165589..168165617
+
Hg19::chr1:197099062..197099073,-p@chr1:197099062..197099073
-
Hg19::chr1:197099076..197099083,-p@chr1:197099076..197099083
-
Hg19::chr1:197099091..197099102,-p@chr1:197099091..197099102
-
Hg19::chr1:39851487..39851521,+p@chr1:39851487..39851521
+
Hg19::chr20:36713497..36713503,+p19@RPRD1B
Hg19::chr22:43355701..43355741,-p14@PACSIN2
Hg19::chr2:123706107..123706109,-p@chr2:123706107..123706109
-
Hg19::chr2:135893438..135893485,+p@chr2:135893438..135893485
+
Hg19::chr2:140624829..140624870,+p@chr2:140624829..140624870
+
Hg19::chr2:159375045..159375057,+p@chr2:159375045..159375057
+
Hg19::chr2:165630270..165630300,-p10@COBLL1
Hg19::chr2:165630301..165630310,-p39@COBLL1
Hg19::chr2:165630313..165630339,-p11@COBLL1
Hg19::chr2:165650899..165650926,-p@chr2:165650899..165650926
-
Hg19::chr2:170115546..170115580,-p@chr2:170115546..170115580
-
Hg19::chr2:170664937..170664947,+p13@SSB
Hg19::chr2:204266094..204266122,+p@chr2:204266094..204266122
+
Hg19::chr3:111812180..111812186,+p@chr3:111812180..111812186
+
Hg19::chr3:120188917..120188936,+p@chr3:120188917..120188936
+
Hg19::chr3:145881495..145881517,-p11@PLOD2
Hg19::chr3:145959753..145959785,-p@chr3:145959753..145959785
-
Hg19::chr3:165535017..165535020,-p@chr3:165535017..165535020
-
Hg19::chr3:165535021..165535029,-p@chr3:165535021..165535029
-
Hg19::chr3:191074565..191074573,+p@chr3:191074565..191074573
+
Hg19::chr3:191074587..191074598,+p@chr3:191074587..191074598
+
Hg19::chr3:191074642..191074664,+p@chr3:191074642..191074664
+
Hg19::chr3:191074675..191074688,+p@chr3:191074675..191074688
+
Hg19::chr3:191074968..191074971,+p@chr3:191074968..191074971
+
Hg19::chr3:191074978..191074992,+p@chr3:191074978..191074992
+
Hg19::chr3:191075002..191075014,+p@chr3:191075002..191075014
+
Hg19::chr3:191075031..191075040,+p@chr3:191075031..191075040
+
Hg19::chr3:191075256..191075261,+p@chr3:191075256..191075261
+
Hg19::chr3:37986042..37986090,-p@chr3:37986042..37986090
-
Hg19::chr4:106656882..106656914,+p@chr4:106656882..106656914
+
Hg19::chr4:44869447..44869474,+p@chr4:44869447..44869474
+
Hg19::chr4:71108300..71108323,+p1@CSN3
Hg19::chr4:73435069..73435082,-p@chr4:73435069..73435082
-
Hg19::chr4:79475019..79475042,+p6@ANXA3
Hg19::chr4:79475120..79475133,+p5@ANXA3
Hg19::chr5:107631924..107631930,-p@chr5:107631924..107631930
-
Hg19::chr5:107631933..107631940,-p@chr5:107631933..107631940
-
Hg19::chr5:107631942..107631951,-p@chr5:107631942..107631951
-
Hg19::chr5:13428853..13428866,+p@chr5:13428853..13428866
+
Hg19::chr5:145427166..145427178,+p@chr5:145427166..145427178
+
Hg19::chr5:179894479..179894489,+p@chr5:179894479..179894489
+
Hg19::chr5:80434077..80434082,+p@chr5:80434077..80434082
+
Hg19::chr6:126135900..126135924,+p22@NCOA7
Hg19::chr6:168251020..168251028,+p@chr6:168251020..168251028
+
Hg19::chr6:168251039..168251042,+p@chr6:168251039..168251042
+
Hg19::chr6:19154273..19154282,-p@chr6:19154273..19154282
-
Hg19::chr6:19154283..19154295,-p@chr6:19154283..19154295
-
Hg19::chr6:30449373..30449383,-p@chr6:30449373..30449383
-
Hg19::chr6:45917165..45917177,-p@chr6:45917165..45917177
-
Hg19::chr6:45917192..45917193,-p@chr6:45917192..45917193
-
Hg19::chr6:53658203..53658215,-p@chr6:53658203..53658215
-
Hg19::chr6:64999168..64999210,+p@chr6:64999168..64999210
+
Hg19::chr7:152166747..152166750,+p@chr7:152166747..152166750
+
Hg19::chr7:152166833..152166847,+p@chr7:152166833..152166847
+
Hg19::chr7:33397558..33397583,+p@chr7:33397558..33397583
+
Hg19::chr7:33397752..33397755,+p@chr7:33397752..33397755
+
Hg19::chr7:80365907..80365910,-p@chr7:80365907..80365910
-
Hg19::chr7:80365917..80365926,-p@chr7:80365917..80365926
-
Hg19::chr7:80365936..80365942,-p@chr7:80365936..80365942
-
Hg19::chr8:37728955..37729014,-p@chr8:37728955..37729014
-
Hg19::chr9:123128390..123128421,-p@chr9:123128390..123128421
-
Hg19::chr9:3330877..3330914,-p@chr9:3330877..3330914
-
Hg19::chr9:88939319..88939326,-p25@ZCCHC6
Hg19::chrX:117553200..117553220,+p@chrX:117553200..117553220
+
Hg19::chrX:140048723..140048740,+p@chrX:140048723..140048740
+
Hg19::chrX:32584018..32584035,-p@chrX:32584018..32584035
-
Hg19::chrX:32584039..32584049,-p@chrX:32584039..32584049
-
Hg19::chrX:64898352..64898387,+p10@MSN
Hg19::chrY:8692267..8692276,-p@chrY:8692267..8692276
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0030036actin cytoskeleton organization and biogenesis0.0201157464163886
GO:0030029actin filament-based process0.0201157464163886
GO:0001666response to hypoxia0.0201157464163886
GO:0014065phosphoinositide 3-kinase cascade0.0201157464163886
GO:0048715negative regulation of oligodendrocyte differentiation0.0201157464163886
GO:0021897forebrain astrocyte development0.0201157464163886
GO:0021896forebrain astrocyte differentiation0.0201157464163886
GO:0048745smooth muscle development0.0201157464163886
GO:0048485sympathetic nervous system development0.0201157464163886
GO:0048713regulation of oligodendrocyte differentiation0.0201157464163886
GO:0022011myelination in the peripheral nervous system0.0201157464163886
GO:0048854brain morphogenesis0.0201157464163886
GO:0032292ensheathment of axons in the peripheral nervous system0.0201157464163886
GO:0048853forebrain morphogenesis0.0201157464163886
GO:0043409negative regulation of MAPKKK cascade0.0201157464163886
GO:0048844artery morphogenesis0.0201157464163886
GO:0014014negative regulation of gliogenesis0.0201157464163886
GO:0045686negative regulation of glial cell differentiation0.0201157464163886
GO:0043535regulation of blood vessel endothelial cell migration0.0201157464163886
GO:0008334histone mRNA metabolic process0.0201157464163886
GO:0019834phospholipase A2 inhibitor activity0.0201157464163886
GO:0008475procollagen-lysine 5-dioxygenase activity0.0201157464163886
GO:0007406negative regulation of neuroblast proliferation0.0201157464163886
GO:0014044Schwann cell development0.0201157464163886
GO:0048483autonomic nervous system development0.0201157464163886
GO:0014037Schwann cell differentiation0.0201157464163886
GO:0021987cerebral cortex development0.0232400732033849
GO:0050890cognition0.0232400732033849
GO:0043534blood vessel endothelial cell migration0.0232400732033849
GO:0014002astrocyte development0.0232400732033849
GO:0008092cytoskeletal protein binding0.0264037330716217
GO:0008486diphosphoinositol-polyphosphate diphosphatase activity0.0264037330716217
GO:0030325adrenal gland development0.0264037330716217
GO:0045124regulation of bone resorption0.0307290422170373
GO:0021543pallium development0.0307290422170373
GO:0045685regulation of glial cell differentiation0.0307290422170373
GO:0014013regulation of gliogenesis0.0307290422170373
GO:0032320positive regulation of Ras GTPase activity0.0307290422170373
GO:0008542visual learning0.0307290422170373
GO:0007010cytoskeleton organization and biogenesis0.0307290422170373
GO:0048708astrocyte differentiation0.0339818460437372
GO:0043525positive regulation of neuron apoptosis0.0373116614685102
GO:0007632visual behavior0.0375400593471159
GO:0001889liver development0.0375400593471159
GO:0030199collagen fibril organization0.0375400593471159
GO:0021510spinal cord development0.0375400593471159
GO:0030867rough endoplasmic reticulum membrane0.0375400593471159
GO:0021537telencephalon development0.0375400593471159
GO:0042308negative regulation of protein import into nucleus0.0375400593471159
GO:0042992negative regulation of transcription factor import into nucleus0.0375400593471159
GO:0048709oligodendrocyte differentiation0.0375400593471159
GO:0050768negative regulation of neurogenesis0.0376951644035807
GO:0001937negative regulation of endothelial cell proliferation0.0376951644035807
GO:0046823negative regulation of nucleocytoplasmic transport0.0376951644035807
GO:0043542endothelial cell migration0.0376951644035807
GO:0048593camera-type eye morphogenesis0.0376951644035807
GO:0045453bone resorption0.0376951644035807
GO:0051224negative regulation of protein transport0.0376951644035807
GO:0021782glial cell development0.0376951644035807
GO:0001952regulation of cell-matrix adhesion0.0376951644035807
GO:0043408regulation of MAPKKK cascade0.0427637789090141
GO:0007405neuroblast proliferation0.0454643875921512
GO:0001936regulation of endothelial cell proliferation0.0454643875921512
GO:0005791rough endoplasmic reticulum0.0454643875921512
GO:0007612learning0.0454643875921512
GO:0004859phospholipase inhibitor activity0.0458540850453024
GO:0016998cell wall catabolic process0.0458540850453024
GO:0048871multicellular organismal homeostasis0.0458540850453024
GO:0001935endothelial cell proliferation0.0458540850453024
GO:0055102lipase inhibitor activity0.0458540850453024
GO:0030336negative regulation of cell migration0.0458540850453024
GO:0001894tissue homeostasis0.0458540850453024
GO:0010382cell wall metabolic process0.0469532635158058
GO:0007047cell wall organization and biogenesis0.0469532635158058
GO:0042990regulation of transcription factor import into nucleus0.0469930026170049
GO:0042991transcription factor import into nucleus0.0469930026170049
GO:0006400tRNA modification0.0469930026170049
GO:0042306regulation of protein import into nucleus0.0469930026170049
GO:0045229external encapsulating structure organization and biogenesis0.0469930026170049
GO:0031418L-ascorbic acid binding0.0469930026170049
GO:0033157regulation of intracellular protein transport0.0469930026170049
GO:0051271negative regulation of cell motility0.0469930026170049
GO:0000049tRNA binding0.0469930026170049
GO:0007422peripheral nervous system development0.0469930026170049
GO:0043407negative regulation of MAP kinase activity0.0469930026170049
GO:0040013negative regulation of locomotion0.0469930026170049
GO:0046850regulation of bone remodeling0.0469930026170049
GO:0001656metanephros development0.0469930026170049
GO:0001649osteoblast differentiation0.0469930026170049
GO:0043523regulation of neuron apoptosis0.0469930026170049
GO:0032386regulation of intracellular transport0.0469930026170049
GO:0048592eye morphogenesis0.0469930026170049
GO:0051349positive regulation of lyase activity0.0469930026170049
GO:0042552myelination0.0469930026170049
GO:0045762positive regulation of adenylate cyclase activity0.0469930026170049
GO:0031281positive regulation of cyclase activity0.0469930026170049
GO:0006928cell motility0.0485635400987374
GO:0051674localization of cell0.0485635400987374
GO:0051223regulation of protein transport0.0485635400987374
GO:0006383transcription from RNA polymerase III promoter0.0485635400987374
GO:0046822regulation of nucleocytoplasmic transport0.0493015702913813
GO:0010001glial cell differentiation0.0493015702913813



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.